In a letter to the Massachusetts Health Policy Commission, state Attorney General (AG) Maura Healey voiced concerns about the proposed merger between Boston-based Beth Israel Deaconess Medical Center, Burlington, Massachusetts-based Lahey Health and three other healthcare organizations, according to a report from The Boston Globe.
Ms. Healey wrote in her letter that the merger, which would create the second largest health system by revenue in Massachusetts after Boston-based Partners HealthCare, could cause healthcare costs to increase, limit access to care and destabilize independent hospitals, according to the report.
The Commission is responsible for producing an analysis of how the deal will affect costs, quality and access, but it does not have power to block the merger. Ms. Healey does have the authority to do so, however. Her concerns are the first from a state official. The merger was approved by the Massachusetts Department of Public Health in March and the Public Health Council in April. The deal is still pending approval from Ms. Healey and the federal government, according to The Boston Globe.
The AG’s office told The Boston Globe it plans to discuss the deal with executives from Beth Israel Deaconess and Lahey Health. The report suggests Ms. Healey’s office could seek to limit the merger or add other parameters related to pricing or patient mix to help address her concerns.
Full Content: Boston Globe
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas